News Release: Healthcare Executives Expect M&A, New Segments to Drive 2017 Growth, Capital One Survey Finds


Despite challenges, industry optimism remains high

M&AsBethesda, Md. (January 10, 2017) – Capital One’s annual survey of healthcare leaders has found that merger and acquisition activity is once again expected to be the industry’s preferred growth strategy in the year ahead.  However, nearly one in three executives (31 percent) plan to drive growth by launching new segments or lines of business—a jump from 17 percent last year. Thirty-eight percent of respondents said that M&A transactions would drive their growth plans in 2017—down three percent from 2016—and more than a quarter of respondents (26 percent) pointed to organic growth initiatives as their top growth strategy.

In addition, nearly half of those surveyed expect their capital needs to rise in 2017. Forty-two percent expect that they will require more capital in the year ahead, a sharp rise from 25 percent in last year’s survey.

“With M&A and a strong new business segment outlook, executives are clearly keeping all avenues to growth on the table,” said Al Aria, Senior Managing Director, Capital One Healthcare. “As capital needs rise, it’s critical that companies find a financial partner that understands the healthcare marketplace.”

Capital One’s survey of more than 450 healthcare executives also revealed that potential changes to the Affordable Care Act (ACA) pose the greatest challenges for the industry. Fifty-nine percent of respondents cited ACA changes as their chief concern, a big jump from 33 percent last year. Eighteen percent of those surveyed cited regulatory uncertainty as the industry’s top challenge. This outlook is quite different from last year’s survey, where an equal number of respondents (one-third) identified the ACA and regulatory issues as their top concerns.

Despite these concerns, projections for performance mirrored the findings in Capital One’s 2016 survey. Ninety-four percent of respondents expect their businesses to deliver financial performance on par or better than last year, compared to 95 percent last year. Nearly two-thirds of respondents (61 percent) predict a stronger year ahead, and just seven percent anticipate weaker financials in 2017.

“Even amid some uncertainty, optimism remains high across the healthcare industry,” said Aria. “We look forward to working with our clients to provide financial solutions that help them meet their goals for 2017.”

Capital One Healthcare is a leading provider of financial services to the industry. Customers across healthcare sectors—including senior housing, healthcare services, pharmaceuticals, medical devices, healthcare IT and medical offices—rely on Capital One Healthcare to finance acquisitions, refinance existing debt, support working capital needs and fund growth initiatives. With in-depth expertise, our team of professionals creates solutions tailored to meet the needs of our customers.


The Capital One survey, conducted between Nov. 29 and Dec. 22, 2016, asked professionals to provide their industry and company outlook for 2017. Respondents included more than 450 senior executives from healthcare companies, including pharmaceutical, healthcare IT and medical technology companies, hospitals, healthcare service providers and health systems, as well as other industry participants.

About Capital One

Capital One Financial Corporation ( is a financial holding company whose subsidiaries, which include Capital One, N.A., and Capital One Bank (USA), N.A., had $226.0 billion in deposits and $345.1 billion in total assets as of September 30, 2016. Headquartered in McLean, Virginia, Capital One offers a broad spectrum of financial products and services to consumers, small businesses and commercial clients through a variety of channels. Capital One, N.A. has branches located primarily in New York, Louisiana, Texas, Maryland, Virginia, New Jersey and the District of Columbia. A Fortune 500 company, Capital One trades on the New York Stock Exchange under the symbol “COF” and is included in the S&P 100 index.



Press Release Contact:
Liz Weaver

Jake Daubenspeck
Prosek Partners
Associate Vice President
203.254.1300 x107
M: 267.664.8582


The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In